Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Reimbursement Briefs: PCORI Projects; Joint Commission On Alarms

This article was originally published in The Gray Sheet

Executive Summary

PCORI approves 82 new funding awards. The Joint Commission releases “R3 Report.” More reimbursement news in brief.

You may also be interested in...



Reimbursement Briefs: CMS Delivery Reform Results; Hospital Differences Assessed; PCORI Updates

CMS releases results for health care delivery system reform initiatives. Health Affairs study explores differences between high- and low-price hospitals. PCORI adds more high-impact topics to pragmatic studies initiative and approves $5 million to fund methods research.

FDA Scales Back Near-Term Goals For Sentinel Postmarket Data Network

FDA’s Janet Woodcock said the agency has not been able to overcome budgetary restrictions that hamper previously discussed plans to develop the Sentinel postmarket drug safety surveillance system into a much broader national resource.

Joint Commission Goal Reflects Growing Concerns About Alarm Fatigue

The Joint Commission’s release of a national patient safety goal on alarm management demonstrates the growing awareness of medical device alarm safety issues, such as alarm fatigue. Critics say manufacturers must make their devices more interoperable in order to create smarter alarms, but hospital staff must make better use of the alarms as well. FDA is also taking steps to improve alarm management.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT032703

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel